ReP USP - Resultado da busca

Artigo de periodico
Reduction of atherosclerotic lesions by the chemotherapeutic agent carmustine associated to lipid nanoparticles (2016)
Daminelli, Elaine N; Martinelli, Ana E. M; Bulgarelli, Adriana; Freitas, Fatima R; Maranhão, Raul Cavalcante
Source: Cardiovascular Drugs and Therapy. Unidade: FCF
Subjects: ARTERIOSCLEROSE, NANOPARTÍCULAS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAMINELLI, Elaine N et al. Reduction of atherosclerotic lesions by the chemotherapeutic agent carmustine associated to lipid nanoparticles. Cardiovascular Drugs and Therapy, v. 30, n. 5, p. 433-443, 2016Tradução . . Disponível em: https://doi.org/10.1007/s10557-016-6675-0. Acesso em: 23 jun. 2024.
APA
Daminelli, E. N., Martinelli, A. E. M., Bulgarelli, A., Freitas, F. R., & Maranhão, R. C. (2016). Reduction of atherosclerotic lesions by the chemotherapeutic agent carmustine associated to lipid nanoparticles. Cardiovascular Drugs and Therapy, 30( 5), 433-443. doi:10.1007/s10557-016-6675-0
NLM
Daminelli EN, Martinelli AEM, Bulgarelli A, Freitas FR, Maranhão RC. Reduction of atherosclerotic lesions by the chemotherapeutic agent carmustine associated to lipid nanoparticles [Internet]. Cardiovascular Drugs and Therapy. 2016 ; 30( 5): 433-443.[citado 2024 jun. 23 ] Available from: https://doi.org/10.1007/s10557-016-6675-0
Vancouver
Daminelli EN, Martinelli AEM, Bulgarelli A, Freitas FR, Maranhão RC. Reduction of atherosclerotic lesions by the chemotherapeutic agent carmustine associated to lipid nanoparticles [Internet]. Cardiovascular Drugs and Therapy. 2016 ; 30( 5): 433-443.[citado 2024 jun. 23 ] Available from: https://doi.org/10.1007/s10557-016-6675-0
Artigo de periodico
Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits (2015)
Leite Junior, Antonio Carlos de Arruda; Solano, Tatiana V; Tavares, Elaine Rufo; Maranhão, Raul Cavalcante
Source: Cardiovascular Drugs and Therapy. Unidade: FCF
Subjects: QUIMIOTERAPIA COMBINADA, ARTERIOSCLEROSE, NANOPARTÍCULAS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE JUNIOR, Antonio Carlos de Arruda et al. Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits. Cardiovascular Drugs and Therapy, v. 29, n. 1, p. . 15-22, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10557-014-6566-1. Acesso em: 23 jun. 2024.
APA
Leite Junior, A. C. de A., Solano, T. V., Tavares, E. R., & Maranhão, R. C. (2015). Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits. Cardiovascular Drugs and Therapy, 29( 1), . 15-22. doi:10.1007/s10557-014-6566-1
NLM
Leite Junior AC de A, Solano TV, Tavares ER, Maranhão RC. Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits [Internet]. Cardiovascular Drugs and Therapy. 2015 ; 29( 1): . 15-22.[citado 2024 jun. 23 ] Available from: https://doi.org/10.1007/s10557-014-6566-1
Vancouver
Leite Junior AC de A, Solano TV, Tavares ER, Maranhão RC. Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits [Internet]. Cardiovascular Drugs and Therapy. 2015 ; 29( 1): . 15-22.[citado 2024 jun. 23 ] Available from: https://doi.org/10.1007/s10557-014-6566-1
Artigo de periodico
Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits (2013)
Bulgarelli, Adriana; Leite Junior, Antonio Carlos de Arruda; Dias, Adriana Abalen Martins; Maranhão, Raul Cavalcante
Source: Cardiovascular Drugs and Therapy. Unidade: FCF
Subjects: LIPOPROTEÍNAS LDL, ARTRITE REUMATOIDE, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BULGARELLI, Adriana et al. Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits. Cardiovascular Drugs and Therapy, v. 27, n. 6, p. 531-539, 2013Tradução . . Disponível em: https://doi.org/10.1007/s10557-013-6488-3. Acesso em: 23 jun. 2024.
APA
Bulgarelli, A., Leite Junior, A. C. de A., Dias, A. A. M., & Maranhão, R. C. (2013). Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits. Cardiovascular Drugs and Therapy, 27( 6), 531-539. doi:10.1007/s10557-013-6488-3
NLM
Bulgarelli A, Leite Junior AC de A, Dias AAM, Maranhão RC. Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits [Internet]. Cardiovascular Drugs and Therapy. 2013 ; 27( 6): 531-539.[citado 2024 jun. 23 ] Available from: https://doi.org/10.1007/s10557-013-6488-3
Vancouver
Bulgarelli A, Leite Junior AC de A, Dias AAM, Maranhão RC. Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits [Internet]. Cardiovascular Drugs and Therapy. 2013 ; 27( 6): 531-539.[citado 2024 jun. 23 ] Available from: https://doi.org/10.1007/s10557-013-6488-3

USP Schools

ReP

Filtros

Authors

Subjects